BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2011
View Archived Issues
AMP-224 boosts BCG-induced immune responses against bladder cancer
Read More
Preclinical activity of asthma candidate RV-1088 described at American Thoracic Society meeting
Read More
AlloStem Therapeutics designs novel MEK inhibitors
Read More
GlaxoSmithKline prepares new agents against hepatitis C virus
Read More
Phase I trials show AIC-316 is safe and well tolerated
Read More
Post hoc analysis supports selegiline transdermal system for treatment of depression
Read More
Wnt signaling inhibition has therapeutic activity in choroidal neovascularization
Read More
New anticancer antofine and cryptopleurine derivatives disclosed
Read More
Grindeks presents new agent for myocardial infarction
Read More
Phase II study begins for BKM-120 in recurrent glioblastoma
Read More
Gilead Sciences patents novel Toll-like receptor agonists
Read More
Ono Pharmaceutical recaps events of fourth quarter fiscal year 2011
Read More
ACADIA Pharmaceuticals receives NIH grant to develop new ER-beta agonists
Read More
BIBF-1120 moves to phase III in idiopathic pulmonary fibrosis
Read More
Oxford BioMedica presents update on drug pipeline
Read More
Ablynx discloses proof-of-concept phase II data on ozoralizumab in rheumatoid arthritis
Read More
Sprix analgesic nasal spray launched in U.S.
Read More
Merck & Co. and Roche enter into nonexclusive agreements for hepatitis C therapies
Read More
Histogenics acquires ProChon Biotech
Read More
CITN selects recombinant IL-7 CYT-107 for clinical testing at network institutions
Read More
Anacor initiates dosing in phase II trial of AN-2728 and AN-2898 in atopic dermatitis
Read More
ERYtech and Teva sign long-term agreement on Graspa
Read More
Quest Diagnostics acquires Celera
Read More
Shire to acquire Advanced BioHealing
Read More
CryoLife acquires Cardiogenesis
Read More